Lannett Co Inc

Most Recent

  • uploads///Chart  EPS

    Understanding Allergan’s Valuation after the 1Q17 Results

    On May 10, 2017, Allergan (AGN) was trading at a forward PE multiple of ~14.1x, as compared to the industry average of 11.9x.

    By Mike Benson
  • uploads///AdobeStock_
    Earnings Report

    Why Is Lannett Company Soaring Today?

    Generic pharmaceutical player Lannett Company (LCI) entered into a distribution agreement with China-based specialty pharmaceutical firm Sinotherapeutics.

    By Margaret Patrick
  • uploads///Chart
    Company & Industry Overviews

    Allergan’s Valuation Compared to Its Peers

    Allergan’s stock value fell more than 40% over the last 12 months. Analysts estimate that the stock could to return ~39.5% over the next 12 months.

    By Mike Benson
  • uploads///Chart  Segment
    Company & Industry Overviews

    How Are Eli Lilly’s Business Segments Performing?

    Eli Lilly and Co.’s (LLY) overall business is classified into two business segments—Human Pharmaceuticals and Animal Health.

    By Mike Benson
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.